Screening Is Not the Same as Waiting for Symptoms
Most veterinary visits happen after something goes wrong. The dog limps, stops eating, or develops a lump. By that point, the disease process has been underway for weeks, months, or sometimes years. Screening reverses this dynamic: it looks for problems before they become clinical, when treatment options are broader, less invasive, and more likely to succeed.
The challenge is knowing what to screen for and when. A comprehensive metabolic panel on a healthy two-year-old dog generates different clinical value than the same panel on a ten-year-old. Life stage determines risk profile, and risk profile should determine the screening protocol.
The guidelines below draw primarily from AAHA preventive healthcare recommendations, AAHA senior care guidelines, and published veterinary internal medicine literature on wellness testing outcomes.
Puppy Stage: Birth to 12 Months
The puppy period is not just about vaccines. It is the baseline-setting window where you establish reference values that will guide every future health comparison.
What to Screen
Physical examination. At minimum three visits during the first year (often aligned with vaccination schedules at 8, 12, and 16 weeks, with a follow-up at 6 months). Each visit should include:
- weight and body condition scoring with growth tracking
- cardiac auscultation for congenital murmurs (particularly important in breeds predisposed to heart disease such as Cavalier King Charles Spaniels and Boxers)
- orthopedic screening for limb angulation abnormalities, especially in large and giant breeds prone to hip dysplasia
- dental assessment for retained deciduous teeth and malocclusion
- eye examination for congenital abnormalities
Fecal parasite testing. At least two to three fecal examinations during the first year. Intestinal parasites are nearly universal in puppies and can impair growth and nutrient absorption during the most critical developmental window.
Baseline bloodwork. A pre-spay/neuter blood panel (typically around 6 months) serves double duty: it screens for congenital issues and establishes baseline organ values. This panel should include a complete blood count (CBC) and basic chemistry panel (BUN, creatinine, ALT, ALP, glucose, total protein, albumin).
Breed-specific screening. For breeds with known genetic predispositions, early testing can be valuable:
- cardiac screening (echocardiogram) for breeds predisposed to congenital defects
- hip and elbow preliminary evaluation in German Shepherds, Labrador Retrievers, Golden Retrievers, and other large breeds
- ophthalmologic examination (CERF/OFA) for breeds with inherited eye conditions like progressive retinal atrophy
What Can Wait
Thyroid panels, urinalysis, and advanced imaging are generally not indicated in healthy puppies without clinical signs. Screening everything creates noise without improving outcomes.
Adult Stage: 1 to 7 Years (Size-Adjusted)
This is the period most owners undervalue. “My dog is healthy” translates to fewer veterinary visits and less monitoring. But adult dogs are not static, and subclinical disease often begins during this window, particularly in the second half.
Note: for large and giant breeds, the adult-to-senior transition happens earlier. A Great Dane at age 5 is physiologically more comparable to a medium-breed dog at age 8. Adjust screening timelines accordingly.
Annual Screening (Every 12 Months)
Comprehensive physical examination. Including cardiac auscultation, abdominal palpation, lymph node assessment, skin evaluation, and body condition scoring.
Bloodwork. Annual CBC and chemistry panel. The primary value here is trend detection. A single normal BUN tells you little. Five years of BUN values showing a gradual upward drift tells you the kidneys are heading toward trouble before clinical signs appear.
Urinalysis. Starting at age 3 to 4 for most breeds. Urinalysis catches early kidney disease, urinary tract infections, and metabolic abnormalities (dilute urine, proteinuria) that bloodwork can miss.
Fecal testing. Annual fecal examination for intestinal parasites, even in dogs on year-round preventive.
Dental assessment. Professional oral examination at each annual visit with staging of any periodontal disease. By age 3, approximately 80% of dogs show some degree of dental disease, and the systemic effects compound over years.
Breed-Specific Additions
- Cardiac screening: annual or biennial echocardiograms for breeds predisposed to dilated cardiomyopathy (Doberman Pinschers, Great Danes, Irish Wolfhounds)
- Ophthalmologic screening: annual eye exams for breeds prone to cataracts or glaucoma
- Joint imaging: baseline hip/elbow radiographs at age 2 for OFA certification in predisposed breeds, with follow-up if lameness develops
Senior Stage: 7 to 10 Years (Size-Adjusted)
This is where screening investment has its highest return. Disease incidence rises sharply, and early detection at this stage can add months or years of quality life.
For giant breeds, the senior window may begin at age 5 to 6. For small breeds, it may not start until age 9 to 10. The AAHA senior care guidelines recommend shifting to senior protocols at the “last 25% of expected lifespan.”
Biannual Screening (Every 6 Months)
Complete physical examination. Every 6 months rather than annually. Changes in weight, body condition, lymph node size, and cardiac sounds develop more quickly in seniors and warrant closer surveillance.
Expanded bloodwork. CBC, comprehensive chemistry panel (including electrolytes), and thyroid panel (total T4 at minimum, free T4 and TSH if hypothyroidism is suspected). This expanded panel catches thyroid decline, early Cushing’s disease, liver disease, and renal insufficiency.
Complete urinalysis with urine protein-to-creatinine ratio (UPC). The UPC ratio detects proteinuria before clinical kidney disease is apparent. IRIS staging guidelines for chronic kidney disease use UPC alongside creatinine and SDMA to classify disease severity.
Blood pressure measurement. Hypertension is underdiagnosed in dogs and contributes to renal damage, retinal detachment, and cardiac remodeling. A single elevated reading requires confirmation (white coat effect is real in dogs), but trends matter.
Annual Senior Additions
Abdominal ultrasound. Annual imaging of the spleen, liver, kidneys, and adrenal glands. This is particularly important for breeds at high risk of hemangiosarcoma (German Shepherds, Golden Retrievers, Labrador Retrievers), where splenic masses may be detectable before rupture.
Thoracic radiographs. Annual chest films to screen for cardiac enlargement, pulmonary changes, and thoracic masses. Baseline films at the start of the senior window provide comparison for future imaging.
Cognitive screening. Use of validated cognitive assessment tools (such as the Canine Cognitive Dysfunction Rating Scale) to establish baseline cognitive function and track any decline. Early identification of cognitive decline allows earlier intervention with environmental enrichment, dietary modification, and potentially pharmacologic support.
Geriatric Stage: 10+ Years (Size-Adjusted)
Dogs in the geriatric window deserve the most intensive screening because they have the highest disease burden and the narrowest intervention window. For small breeds that routinely live to 14 to 16, geriatric protocols may begin at 12. For giant breeds, the geriatric window may start as early as 7.
Screening Every 4 to 6 Months
Everything in the senior protocol, with these additions:
SDMA (symmetric dimethylarginine). This renal biomarker detects kidney function loss earlier than traditional creatinine, sometimes by months to years. In geriatric dogs where kidney disease prevalence exceeds 20%, SDMA adds meaningful early detection value.
Cardiac biomarkers. NT-proBNP and cardiac troponin I can detect subclinical cardiac disease. In breeds predisposed to mitral valve disease (Cavalier King Charles Spaniels) or DCM, these markers provide earlier warning than auscultation alone.
Orthopedic assessment. Structured evaluation of mobility, muscle mass, and pain using validated scales. Sarcopenia (age-related muscle loss) accelerates in geriatric dogs and directly affects quality of life and fall risk.
Vision and hearing assessment. Sensory decline affects safety, navigation, and cognitive function. Documenting the progression helps owners adapt their environment appropriately.
Trending Values vs. Single Snapshots
One of the most valuable aspects of longitudinal screening is the ability to track trends. A BUN of 28 mg/dL is within normal range. But if that same dog’s BUN was 14 mg/dL three years ago and has been climbing steadily, the trajectory tells a different story than the number alone.
This is why baseline bloodwork matters even in young, healthy dogs. Without baseline values, there is no way to detect gradual organ function changes until they cross the reference range threshold, which may be late in the disease process.
Request copies of all results and keep them organized chronologically. Many veterinary practices now offer client portals where results are stored digitally.
Cost Considerations
The most common objection to screening protocols is cost. A practical approach:
- prioritize bloodwork and urinalysis at every visit (these have the highest information-to-cost ratio)
- add imaging selectively based on breed risk and clinical findings
- discuss with your veterinarian which breed-specific tests are highest priority
- wellness plan pricing at many practices can reduce per-test costs by 20 to 40%
Screening is less expensive than treating late-stage disease. A comprehensive senior blood panel costs a fraction of what emergency kidney failure management costs.
Frequently Asked Questions
How often should a healthy adult dog have bloodwork done? The AAHA guidelines recommend annual bloodwork for adult dogs aged 1 to 7. This establishes trends in organ values and catches subclinical changes early. More frequent testing (every 6 months) is recommended once dogs enter their senior years.
At what age should dogs start senior screening? The general guideline is the “last 25% of expected lifespan.” For small breeds living to 14 to 16, senior screening typically begins around 10 to 11. For large breeds living to 10 to 12, it begins around 7 to 8. For giant breeds living to 7 to 9, it may begin as early as 5 to 6.
Is a urinalysis really necessary if bloodwork is normal? Yes. Urinalysis detects early kidney disease, urinary tract infections, and metabolic changes that bloodwork can miss entirely. Kidney disease in particular can be detected via urinalysis (dilute urine, proteinuria) before BUN or creatinine become elevated.
What is SDMA and why does it matter for older dogs? SDMA (symmetric dimethylarginine) is a kidney biomarker that detects function loss earlier than creatinine, sometimes by months. In geriatric dogs where kidney disease is common, SDMA adds meaningful early detection capability and can trigger earlier dietary or medical intervention.
Should I get a cardiac screening for my dog even without symptoms? For breeds predisposed to heart disease (Cavalier King Charles Spaniel, Doberman Pinscher, Great Dane, Irish Wolfhound, Boxer), cardiac screening before symptoms appear can detect disease when treatment is most effective. For other breeds, cardiac assessment during routine physical exams is generally sufficient unless signs develop.
How do I decide which breed-specific tests my dog needs? Start by identifying your breed’s top genetic health risks. Your veterinarian can help prioritize based on breed, age, and any family history. OFA and breed club health registries list recommended tests by breed.
The Bottom Line
Health screening is the foundation of proactive longevity management. A structured protocol matched to your dog’s life stage catches disease when intervention is cheapest, least invasive, and most effective. The investment in regular baseline tracking pays dividends when values begin to shift, because context turns a number into a trajectory, and trajectories drive earlier, better decisions.
References
- AAHA Preventive Healthcare Guidelines (AAHA, 2021).
- AAHA Senior Care Guidelines for Dogs and Cats (AAHA, 2023).
- Willems A et al. Standardized wellness testing in dogs: a systematic review (Journal of Veterinary Internal Medicine, 2019).
- Davies M. Geriatric screening in first opinion practice: results from 45 dogs (Journal of Small Animal Practice, 2012).